Mirae Asset Global Investments
SYNH

Mirae Asset Global Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Mirae Asset Global Investments’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,409
Closed -$211K – 1793
2021
Q3 		$211K Buy
+2,409
New +$218K ﹤0.01% 1676

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mirae Asset Global Investments's SYNH Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 2,409 shares — an estimated $211K sold.

Mirae Asset Global Investments first reported a position in SYNH in Q3 2021 and held it in 1 quarter. The position peaked at $211K in Q3 2021. 378 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

  • Mirae Asset Global Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,409 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $211K.
  • Mirae Asset Global Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 1 quarter.
  • Mirae Asset Global Investments's Syneos Health, Inc. Class A Common Stock position peaked at $211K in Q3 2021.
  • 378 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.